PBT assessment list
PBT assessment list
PBT assessment list
ECHA’s persistence, bioaccumulation and toxicity (PBT) assessment list includes the substances undergoing a PBT/vPvB assessment that have been brought for discussion to ECHA’s PBT Expert Group.
Inclusion in the list means that an informal hazard assessment for PBT/vPvB properties either is under development or has been completed since February 2013.
For each substance, the table shows the assessing or evaluating Member State (submitter), the outcome from the assessment, and the date of the latest update to the list entry.
Other process details and hazard assessment outcome documents are also available and can be accessed through the ‘Details’ icon.
One possible outcome of such an assessment is that a substance is considered not to have PBT/vPvB properties.
If the outcome is that the substance is considered to have PBT/vPvB properties, confirmation through the formal risk management and decision-making processes is needed before any regulatory action can be taken due to these properties.
The intentions of authorities to submit a dossier to the formal REACH and CLP processes are notified through the Registry of Intentions. All biocidal active substances have to undergo a formal PBT assessment. You can see the status of biocides assessments on the Biocidal Active Substances page.
The information and views set out in the PBT assessment list and in the hazard assessment outcome documents are those of the evaluating authority and do not necessarily reflect the position or opinion of the other Member States or ECHA. Neither ECHA nor the evaluating authority nor any person acting on either of their behalves may be held liable for the use, which may be made of the information contained therein. Statements made or information contained in the documents are without prejudice to any formal regulatory activities that ECHA or the Member States may initiate at a later stage. PBT assessments and their outcomes are compiled on the basis of information available by the date of the publication of the document.
Further information
Last updated 24 Μαΐου 2023. Database contains 228 unique substances/entries.
421-450-8
|
154702-15-5
|
Germany
|
inconclusive
|
24-Μαϊ-2023
|
Details | |
264-120-7
|
63393-96-4
|
Italy
|
inconclusive
|
09-Μαρ-2023
|
Details | |
249-596-6
|
29385-43-1
|
Germany
|
Under development
|
24-Φεβ-2023
|
Details | |
202-394-1
|
95-14-7
|
Germany
|
Under development
|
24-Φεβ-2023
|
Details | |
926-564-6
|
-
|
Germany
|
not PBT
|
20-Φεβ-2023
|
Details | |
273-227-8
|
68953-84-4
|
Germany
|
inconclusive
|
24-Νοε-2022
|
Details | |
217-496-1
|
1873-88-7
|
Norway
|
Under development
|
03-Νοε-2022
|
Details | |
247-426-5
|
26040-51-7
|
Sweden
|
Under development
|
27-Οκτ-2022
|
Details | |
233-593-1
|
10254-57-6
|
Germany
|
Under development
|
27-Οκτ-2022
|
Details | |
201-247-9
|
80-07-9
|
Austria
|
Under development
|
08-Σεπ-2022
|
Details | |
201-983-0
|
90-30-2
|
Germany
|
not PBT not vPvB |
18-Αυγ-2022
|
Details | |
701-337-2
|
-
|
France
|
not PBT not vPvB |
26-Ιουλ-2022
|
Details | |
214-946-9
|
1222-05-5
|
France
|
Under development under SEV
|
30-Ιουν-2022
|
Details | |
204-077-3
|
115-27-5
|
France
|
not PBT not vPvB |
23-Ιουν-2022
|
Details | |
447-780-2
|
-
|
Estonia
|
inconclusive
|
22-Ιουν-2022
|
Details | |
473-390-7
|
-
|
Belgium
|
vPvB
|
22-Ιουν-2022
|
Details | |
444-340-1
|
-
|
Germany
|
inconclusive
|
22-Ιουν-2022
|
Details | |
272-486-4
|
68855-45-8
|
France
|
inconclusive
|
22-Ιουν-2022
|
Details | |
203-497-4
|
107-51-7
|
Norway
|
vPvB not PBT |
22-Ιουν-2022
|
Details | |
205-492-2
|
141-63-9
|
Norway
|
vPvB not PBT |
22-Ιουν-2022
|
Details | |
205-491-7
|
141-62-8
|
Norway
|
vPvB not PBT |
22-Ιουν-2022
|
Details | |
627-083-1
|
244235-47-0
|
Spain
|
not PBT not vPvB |
22-Ιουν-2022
|
Details | |
270-128-1
|
68411-46-1
|
Germany
|
Under development under SEV
|
31-Μαϊ-2022
|
Details | |
448-020-2
|
-
|
Slovakia
|
postponed
|
28-Απρ-2022
|
Details | |
428-970-4
|
13595-25-0
|
Belgium
|
postponed
|
28-Απρ-2022
|
Details | |
204-661-8
|
123-91-1
|
Germany
|
21-Απρ-2022
|
Details | ||
246-677-8
|
25155-23-1
|
Italy
|
inconclusive
|
07-Απρ-2022
|
Details | |
284-660-7
|
84961-70-6
|
Italy
|
inconclusive
|
07-Απρ-2022
|
Details | |
701-171-0
|
-
|
Germany
|
Under development under SEV
|
24-Μαρ-2022
|
Details | |
215-958-7
|
1461-22-9
|
ECHA
|
postponed
|
17-Μαρ-2022
|
Details | |
234-118-0
|
10540-29-1
|
ECHA
|
postponed
|
17-Μαρ-2022
|
Details | |
700-427-9
|
-
|
Belgium
|
postponed
|
17-Μαρ-2022
|
Details | |
IRGANOX L 118
|
404-800-4
|
118832-72-7
|
Germany
|
postponed
|
17-Μαρ-2022
|
Details |
239-349-0
|
15307-93-4
|
To Be Defined
|
postponed
|
17-Μαρ-2022
|
Details | |
204-278-6
|
118-79-6
|
Norway
|
postponed
|
17-Μαρ-2022
|
Details | |
260-126-9
|
56358-17-9
|
To Be Defined
|
postponed
|
10-Μαρ-2022
|
Details | |
201-557-4
|
84-74-2
|
ECHA
|
postponed
|
10-Μαρ-2022
|
Details | |
205-426-2
|
140-66-9
|
ECHA
|
postponed
|
10-Μαρ-2022
|
Details | |
253-781-7
|
38103-06-9
|
Germany
|
postponed
|
10-Μαρ-2022
|
Details | |
442-200-4
|
-
|
To Be Defined
|
postponed
|
10-Μαρ-2022
|
Details | |
255-647-3
|
42074-68-0
|
Netherlands
|
postponed
|
10-Μαρ-2022
|
Details | |
235-869-7
|
13014-24-9
|
Netherlands
|
postponed
|
10-Μαρ-2022
|
Details | |
262-975-0
|
61788-44-1
|
Germany
|
Under development under SEV
|
03-Μαρ-2022
|
Details | |
400-820-2
|
84268-33-7
|
Spain
|
not PBT not vPvB |
01-Φεβ-2022
|
Details | |
EVERSORB 80; TINUVIN 1130; TINUVIN 213
|
400-830-7
|
-
|
Sweden
|
not PBT not vPvB |
01-Φεβ-2022
|
Details |
CGL 384; TINUVIN 384
|
407-000-3
|
127519-17-9
|
Spain
|
not PBT not vPvB |
01-Φεβ-2022
|
Details |
630-348-4
|
84268-36-0
|
Spain
|
not PBT not vPvB |
01-Φεβ-2022
|
Details | |
448-060-0
|
727678-39-9
|
Germany
|
Under development
|
27-Ιαν-2022
|
Details | |
200-673-2
|
67-97-0
|
Sweden
|
not PBT not vPvB |
05-Ιαν-2022
|
Details | |
HELVETOLIDE
|
415-490-5
|
141773-73-1
|
Germany
|
not PBT not vPvB |
20-Δεκ-2021
|
Details |
EU Privacy Disclaimer
Ο παρών ιστότοπος χρησιμοποιεί cookies για να διασφαλίζεται ότι αποκομίζετε την καλύτερη δυνατή εμπειρία από την περιήγησή σας στους ιστοτόπους μας.